Breast cancer prevention strategies for the twenty-first century

Molecular Medicine Today
S Sukumar, K McKenzie

Abstract

The incidence of breast cancer has reached epidemic proportions in most Western developed countries. The breast cancer rate is three times higher than in developing countries. In the USA alone, one in eight women will develop breast cancer during her lifetime. Molecular medicine has allowed us to make great advances in understanding disease susceptibility and pathogenesis. It has also let us forge inroads into the genetic screening of women who have a family history of breast cancer. However, women who have been classified as members of the high-risk groups have expectations of effective prevention or prophylactic therapy that cannot, as yet, be delivered. It is time to give serious consideration to the emerging prophylactic strategies that take advantage of the advances in molecular techniques in order to address this deficit.

References

Aug 6, 1992·The New England Journal of Medicine·T F DeLaney, L J Pierce
Oct 1, 1995·Scientific American·D L Davis, H L Bradlow
Sep 30, 1995·Lancet·B S Hulka, A T Stark
Jul 1, 1995·Geriatric Nursing·C A Miller
Jan 1, 1994·Breast Cancer Research and Treatment·V C Jordan
Aug 1, 1994·Neurology·A H Rajput, R J Uitti
Jan 18, 1996·The New England Journal of Medicine·A A LangstonE A Ostrander
May 1, 1996·Molecular Medicine Today·D A Tonetti, V C Jordan
Jun 28, 1996·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M TakahashiJ Uchino

❮ Previous
Next ❯

Citations

Apr 1, 1997·Molecular Medicine Today·P Murphy, W Bray
Nov 30, 2006·Nursing Research·Diana LithgowChandice Covington
Nov 4, 2005·Biological Research for Nursing·Diana Lithgow, Chandice Covington
Oct 27, 1997·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·A Luz
Oct 3, 2007·Biological Research for Nursing·Diana LithgowChandice Covington

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.